Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Convey Holding Parent initiated with a Neutral at JPMorgan » 08:19
07/12/21
07/12
08:19
07/12/21
08:19
CNVY

Convey Holding Parent

$9.83 /

+0.405 (+4.30%)

JPMorgan analyst Anne…

JPMorgan analyst Anne Samuel initiated coverage of Convey Holding Parent with a Neutral rating and $12 price target. The analyst views Convey as a play on the growing Medicare Advantage market with profitable growth. The analyst says that while the industry backdrop is favorable, the company's growth is expected to come largely from the existing customer base versus new wins. The customer concentration keeps Samuel at Neutral.

ShowHide Related Items >><<
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

07/12/21 Canaccord
Convey Holding Parent initiated with a Buy at Canaccord
07/12/21 Truist
Convey Holding Parent initiated with a Buy at Truist
07/12/21 BofA
Convey initiated with a Buy at BofA
07/12/21 Barclays
Convey Holding Parent initiated with an Overweight at Barclays
  • 16
    Jun
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

Initiation
Convey Holding Parent initiated with a Buy at Canaccord » 07:24
07/12/21
07/12
07:24
07/12/21
07:24
CNVY

Convey Holding Parent

$9.83 /

+0.405 (+4.30%)

Canaccord analyst Richard…

Canaccord analyst Richard Close initiated coverage of Convey Holding Parent with a Buy rating and $18 price target. Convey looks uniquely positioned for sustained profitable growth for many years to come, Close tells investors in a research note. There remains plenty of runway for cross-sell growth within its 162 clients that Close believes can support 15%+ growth in revenue and 20%+ in adjusted EBITDA long term, the analyst adds.

ShowHide Related Items >><<
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

07/12/21 Truist
Convey Holding Parent initiated with a Buy at Truist
07/12/21 BofA
Convey initiated with a Buy at BofA
07/12/21 Barclays
Convey Holding Parent initiated with an Overweight at Barclays
07/11/21 Goldman Sachs
Convey Health initiated with a Buy at Goldman Sachs
  • 16
    Jun
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

Initiation
Convey Holding Parent initiated with a Buy at Truist » 07:17
07/12/21
07/12
07:17
07/12/21
07:17
CNVY

Convey Holding Parent

$9.83 /

+0.405 (+4.30%)

Truist analyst Sandy…

Truist analyst Sandy Draper initiated coverage of Convey Holding Parent with a Buy rating and $16 price target. Convey's business is multifaceted with a tech-enabled solutions business as well as an advisory business which complement one another to maximize value for the company's clients, Draper tells investors in a research note. Its business model is sticky, with high visibility and strong EBITDA margins, the analyst adds.

ShowHide Related Items >><<
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

07/12/21 BofA
Convey initiated with a Buy at BofA
07/12/21 Barclays
Convey Holding Parent initiated with an Overweight at Barclays
07/11/21 Goldman Sachs
Convey Health initiated with a Buy at Goldman Sachs
  • 16
    Jun
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

Initiation
Convey initiated with a Buy at BofA » 06:42
07/12/21
07/12
06:42
07/12/21
06:42
CNVY

Convey Holding Parent

$9.83 /

+0.405 (+4.30%)

BofA analyst Michael…

BofA analyst Michael Cherny initiated coverage of Convey Holding Parent, the holding company of Convey Health, with a Buy rating and $15 price target. Convey provides back office technology platforms and additional value-added services designed to ease the administrative burden of healthcare payers and the opportunity for upsell within its existing base remains significant, Cherny tells investors.

ShowHide Related Items >><<
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

07/12/21 Barclays
Convey Holding Parent initiated with an Overweight at Barclays
07/11/21 Goldman Sachs
Convey Health initiated with a Buy at Goldman Sachs
  • 16
    Jun
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

Initiation
Convey Holding Parent initiated with an Overweight at Barclays » 05:28
07/12/21
07/12
05:28
07/12/21
05:28
CNVY

Convey Holding Parent

$9.83 /

+0.405 (+4.30%)

Barclays analyst Steve…

Barclays analyst Steve Valiquette initiated coverage of Convey Holding Parent with an Overweight rating and $16 price target. Convey is a healthcare technology company that specializes in offering products and services to government sponsored health plans, Valiquette tells investors in a research note. He believes the company Convey has a "unique opportunity to up-sell and cross-sell to existing clients."

ShowHide Related Items >><<
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

07/11/21 Goldman Sachs
Convey Health initiated with a Buy at Goldman Sachs
  • 16
    Jun
CNVY Convey Holding Parent
$9.83 /

+0.405 (+4.30%)

Initiation
Convey Health initiated with a Buy at Goldman Sachs » 19:43
07/11/21
07/11
19:43
07/11/21
19:43
CNVY

Convey Health

$9.83 /

+0.405 (+4.30%)

Goldman Sachs analyst…

Goldman Sachs analyst George Tong initiated coverage of Convey Health with a Buy rating and $21 price target. The analyst believes Convey Health's technology and services platform purpose-built for government-sponsored health plans confers a wide competitive moat capable of sustaining robust 15%-plus average annual organic revenue growth, with growth tailwinds from a large addressable market, MA member growth, rising supplemental benefits utilization and cross-selling. Tong expects margin expansion from mix to drive 20%-plus average annual EBITDA growth and a positive multiple re-rating.

ShowHide Related Items >><<
  • 16
    Jun
CNVY Convey Health
$9.83 /

+0.405 (+4.30%)

Over a month ago
On The Fly
Opening Day: WalkMe stock price falls following $287M IPO » 08:34
06/19/21
06/19
08:34
06/19/21
08:34
CYT

Cyteir Therapeutics

$17.18 /

+0.18 (+1.06%)

, FEMY

Femasys

$12.45 /

-0.79 (-5.97%)

, AMAM

Ambrx Biopharma

$17.60 /

-0.26 (-1.46%)

, DNAY

Codex DNA

$19.06 /

+0.45 (+2.42%)

, TRMR

Tremor International

$17.92 /

+ (+0.00%)

, ATAI

Atai Life Sciences

$19.50 /

+ (+0.00%)

, IPSC

Century Therapeutics

$22.46 /

+2.98 (+15.30%)

, RERE

AiHuiShou

$16.80 /

-1.56 (-8.50%)

, VERV

Verve Therapeutics

$38.76 /

+7.115 (+22.49%)

, LYEL

Lyell Immunopharma

$16.20 /

-0.6 (-3.57%)

, ISPC

iSpecimen

$7.40 /

+0.29 (+4.08%)

, WKME

WalkMe

$28.83 /

-0.17 (-0.59%)

, MOLN

Molecular Partners

$19.29 /

-0.59 (-2.97%)

, CNVY

Convey Health

$12.20 /

-0.505 (-3.97%)

, ALZN

Alzamend Neuro

$9.01 /

-1.01 (-10.08%)

, FLYW

Flywire

$33.80 /

+1.45 (+4.48%)

, PAY

Paymentus

$29.20 /

-0.53 (-1.78%)

, ZIP

ZipRecruiter

$21.26 /

+0.56 (+2.71%)

, DAWN

Day One Biopharmaceuticals

$21.42 /

+2.1899 (+11.39%)

, FIGS

Figs

$36.55 /

+0.04 (+0.11%)

, OMIC

Singular Genomics

$23.90 /

-0.34 (-1.40%)

, CNTA

Centessa

$24.87 /

-0.57 (-2.24%)

, DIDI

DiDi

$14.23 /

-2.43 (-14.59%)

, QNIU

Qiniu

/

+

, RGCB

Regencell Bioscience

/

+

, ELEV

Elevation Oncology

$13.25 /

+0.61 (+4.83%)

, CMSL

Camposol

/

+

, DNUT

Krispy Kreme

/

+

, YOU

Clear Secure

$42.88 /

+4.28 (+11.09%)

, GS

Goldman Sachs

$348.74 /

-12.86 (-3.56%)

, MS

Morgan Stanley

$84.05 /

-3.86 (-4.39%)

, JPM

JPMorgan

$147.87 /

-3.92 (-2.58%)

, AMZN

Amazon.com

$3,486.78 /

-7.155 (-0.20%)

, F

Ford

$14.52 /

-0.25 (-1.69%)

, SAFO

Save Foods

/

+

, HOOD

Robinhood

/

+

Backed by Insight Venture…

ShowHide Related Items >><<
WKME WalkMe
$28.83 /

-0.17 (-0.59%)

MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

HOOD Robinhood
/

+

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

FLYW Flywire
$33.80 /

+1.45 (+4.48%)

F Ford
$14.52 /

-0.25 (-1.69%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

CYT Cyteir Therapeutics
$17.18 /

+0.18 (+1.06%)

FEMY Femasys
$12.45 /

-0.79 (-5.97%)

AMAM Ambrx Biopharma
$17.60 /

-0.26 (-1.46%)

DNAY Codex DNA
$19.06 /

+0.45 (+2.42%)

TRMR Tremor International
$17.92 /

+ (+0.00%)

ATAI Atai Life Sciences
$19.50 /

+ (+0.00%)

IPSC Century Therapeutics
$22.46 /

+2.98 (+15.30%)

RERE AiHuiShou
$16.80 /

-1.56 (-8.50%)

VERV Verve Therapeutics
$38.76 /

+7.115 (+22.49%)

LYEL Lyell Immunopharma
$16.20 /

-0.6 (-3.57%)

06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
ISPC iSpecimen
$7.40 /

+0.29 (+4.08%)

WKME WalkMe
$28.83 /

-0.17 (-0.59%)

MOLN Molecular Partners
$19.29 /

-0.59 (-2.97%)

06/21/21 H.C. Wainwright
Molecular Partners assumed with a Buy at H.C. Wainwright
CNVY Convey Health
$12.20 /

-0.505 (-3.97%)

ALZN Alzamend Neuro
$9.01 /

-1.01 (-10.08%)

FLYW Flywire
$33.80 /

+1.45 (+4.48%)

06/21/21
Fly Intel: Top five analyst initiations
06/21/21 JPMorgan
Flywire initiated with an Overweight at JPMorgan
06/21/21 Raymond James
Flywire initiated with an Outperform at Raymond James
06/21/21 Raymond James
Flywire initiated with an Outperform at Raymond James
PAY Paymentus
$29.20 /

-0.53 (-1.78%)

06/21/21 JPMorgan
Paymentus initiated with a Neutral at JPMorgan
06/21/21 Raymond James
Paymentus initiated with an Outperform at Raymond James
06/21/21 Baird
Paymentus risk/reward seen positive, Baird starts with Outperform
06/21/21 Wells Fargo
Paymentus initiated with an Overweight at Wells Fargo
ZIP ZipRecruiter
$21.26 /

+0.56 (+2.71%)

06/21/21 JPMorgan
ZipRecruiter initiated with a Neutral at JPMorgan
06/21/21 Evercore ISI
Evercore ISI starts 'differentiated' ZipRecruiter at Outperform
06/21/21 Raymond James
ZipRecruiter initiated with a Strong Buy at Raymond James
DAWN Day One Biopharmaceuticals
$21.42 /

+2.1899 (+11.39%)

06/21/21 Cowen
Cowen starts Day One with Outperform on glioma potential
06/21/21 JPMorgan
Day One Biopharmaceuticals initiated with an Overweight at JPMorgan
06/21/21 Wedbush
Day One Biopharmaceuticals initiated with an Outperform at Wedbush
06/21/21 Wedbush
Day One Biopharmaceuticals initiated with an Outperform at Wedbush
FIGS Figs
$36.55 /

+0.04 (+0.11%)

06/21/21 Guggenheim
Figs initiated with a Buy at Guggenheim
06/21/21 Cowen
Cowen starts Figs at Outperform, sees path to market cap over $8B
06/21/21 Cowen
Figs initiated with an Outperform at Cowen
OMIC Singular Genomics
$23.90 /

-0.34 (-1.40%)

06/21/21 Cowen
Cowen starts 'promising' Singular Genomics with Outperform rating
06/21/21 JPMorgan
Singular Genomics initiated with an Overweight at JPMorgan
06/21/21 BofA
Singular Genomics initiated with a Neutral at BofA
06/21/21 Cowen
Singular Genomics initiated with an Outperform at Cowen
CNTA Centessa
$24.87 /

-0.57 (-2.24%)

06/22/21
Fly Intel: Top five analyst initiations
06/22/21 Jefferies
Centessa initiated with a Buy at Jefferies
06/22/21 Morgan Stanley
Centessa initiated with an Overweight at Morgan Stanley
06/22/21 Goldman Sachs
Centessa initiated with a Buy at Goldman Sachs
DIDI DiDi
$14.23 /

-2.43 (-14.59%)

QNIU Qiniu
/

+

RGCB Regencell Bioscience
/

+

ELEV Elevation Oncology
$13.25 /

+0.61 (+4.83%)

CMSL Camposol
/

+

DNUT Krispy Kreme
/

+

YOU Clear Secure
$42.88 /

+4.28 (+11.09%)

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

06/17/21 JMP Securities
Goldman Sachs price target raised to $425 from $400 at JMP Securities
06/16/21 JPMorgan
Goldman Sachs price target raised to $452 from $351 at JPMorgan
06/09/21 Jefferies
Jefferies starts 'too cheap' Goldman Sachs at Buy
06/09/21 Jefferies
Goldman Sachs initiated with a Buy at Jefferies
MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

06/29/21 Evercore ISI
Evercore says Morgan Stanley the 'standout' on capital plan among DFAST banks
06/16/21 JPMorgan
Morgan Stanley price target raised to $105 from $85 at JPMorgan
06/09/21 Jefferies
Jefferies starts 'compelling compounder' Morgan Stanley at Buy
06/09/21 Jefferies
Morgan Stanley initiated with a Buy at Jefferies
JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

06/15/21 BMO Capital
JPMorgan price target trimmed to $139 at BMO Capital on reduced NII view
06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

06/24/21 Cowen
Cowen says vote on first antitrust bill encouraging for big tech
06/24/21 Morgan Stanley
Amazon Prime Day revenue up 7% year-over-year, says Morgan Stanley
06/24/21 Piper Sandler
Amazon Prime Day sales rose 13% over last year, says Piper Sandler
06/22/21 Truist
Wayfair's clearance event looks to capitalize on Prime Day effects, says Truist
F Ford
$14.52 /

-0.25 (-1.69%)

06/29/21 UBS
Ford price target raised to $16 from $13 at UBS
06/22/21 Barclays
Ford price target raised to $17 from $15 at Barclays
06/04/21 JPMorgan
Ford price target raised to $18 from $16 at JPMorgan
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
SAFO Save Foods
/

+

HOOD Robinhood
/

+

MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

F Ford
$14.52 /

-0.25 (-1.69%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

  • 18
    Jun
  • 18
    Jun
  • 18
    Jun
  • 18
    Jun
  • 17
    Jun
  • 18
    Jun
  • 18
    Jun
  • 18
    Jun
  • 17
    Jun
  • 16
    Jun
  • 16
    Jun
  • 17
    Jun
  • 16
    Jun
  • 27
    May
  • 28
    May
  • 27
    May
  • 27
    May
  • 26
    May
  • 26
    May
  • 26
    May
MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

HOOD Robinhood
/

+

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

F Ford
$14.52 /

-0.25 (-1.69%)

DIDI DiDi
$14.23 /

-2.43 (-14.59%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

WKME WalkMe
$28.83 /

-0.17 (-0.59%)

SAFO Save Foods
/

+

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

HOOD Robinhood
/

+

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

F Ford
$14.52 /

-0.25 (-1.69%)

DIDI DiDi
$14.23 /

-2.43 (-14.59%)

DAWN Day One Biopharmaceuticals
$21.42 /

+2.1899 (+11.39%)

CYT Cyteir Therapeutics
$17.18 /

+0.18 (+1.06%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

FIGS Figs
$36.55 /

+0.04 (+0.11%)

F Ford
$14.52 /

-0.25 (-1.69%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

Syndicate
Convey Health opens at $14, IPO priced at $14 » 10:23
06/16/21
06/16
10:23
06/16/21
10:23
CNVY

Convey Holding Parent

/

+

Convey Health (CNVY)…

Convey Health (CNVY) priced 13.333M shares at $14.00. The deal priced at the low end of the $14.00-$16.00 range. BofA, Goldman Sachs and JPMorgan acted as joint book running managers for the offering. Convey Health is a specialized healthcare technology and services company that offers administrative solutions for government-sponsored health plans to "optimize member interactions, ensure compliance, and support end-to-end Medicare processes."

ShowHide Related Items >><<
  • 16
    Jun
Syndicate
Convey Holding 13.333M share IPO priced at $14.00 » 19:44
06/15/21
06/15
19:44
06/15/21
19:44
CNVY

Convey Holding Parent

/

+

The deal priced at low…

The deal priced at low end of $14.00-$16.00 range. BofA, Goldman Sachs and JPMorgan are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 16
    Jun
Syndicate
Convey Health Solutions announces launch of initial public offering » 15:23
06/07/21
06/07
15:23
06/07/21
15:23
CNVY

Convey Health

/

+

Convey Health announced…

Convey Health announced it has launched the roadshow for the initial public offering of 13.33M shares of its common stock, with 11.67M shares to be offered by the company and 1.67M shares to be offered by a selling stockholder pursuant to a registration statement filed on Form S-1 with the SEC. The price range for the initial public offering is currently estimated to be between $14.00-$16.00 per share. The company has applied to list its common stock on the New York Stock Exchange under the ticker symbol "CNVY." The company intends to use the net proceeds that it receives from the proposed offering to repay amounts outstanding under its existing indebtedness and for general corporate purposes. The company will not receive any proceeds from the sale of shares of common stock by the selling stockholder. BofA Securities, Goldman Sachs, and J.P. Morgan are acting as lead book-runners and representatives of the underwriters for the offering, with Barclays acting as a joint book-runner. TPG Capital BD and Truist Securities are also acting as joint book-runners for the offering, and Canaccord Genuity is acting as joint lead manager. AmeriVet Securities and Siebert Williams Shank are acting as co-managers for the offering.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.